Key result
Fixed-dose perindopril/indapamide lowers clinic systolic blood pressure by ~31 mmHg in uncontrolled hypertension.
Why the study?
Blood pressure control remains inadequate in subjects with uncontrolled arterial hypertension despite treatment with high doses of ACE inhibitors or angiotensin II receptor antagonists, alone or in combination with other agents.
Does switching to a fixed-dose combination of perindopril 10 mg and indapamide 2.5 mg improve blood pressure control in non-diabetic subjects with previously uncontrolled arterial hypertension?
Does switching to a fixed-dose combination of perindopril 10 mg and indapamide 2.5 mg improve blood pressure control in non-diabetic subjects with previously uncontrolled arterial hypertension?
Switching to a high-dose fixed combination of perindopril and indapamide significantly reduces clinic and ambulatory blood pressure in patients with previously uncontrolled hypertension.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for optimizing BP control in uncontrolled hypertension on ACEi/ARA; larger randomized trials needed.
Objective. To improve blood pressure (BP) control in subjects with uncontrolled arterial hypertension treated by monotherapy with high doses of ACE inhibitors (ACEi) or angiotensin II receptor antagonists (ARA) or with the combination of ACEi or ARA with another antihypertensive agent in moderate doses. Design and methods. Forty six non-diabetic hypertensive subjects with clinic BP > 150/90 mmHg on monotherapy and > 140/90 mmHg on combination therapy with daytime ambulatory BP > 135/85 mmHg were switched to fixed-dose combination of perindopril A 10 mg/indapamide 2,5 mg for 12 weeks. Clinic and ambulatory BP measurements and laboratory evaluations were performed. Results. At baseline 39 % subjects received combination therapy, clinic BP was 162,6 ± 4,2/98 ± 3,0 mmHg, 24-h BP 146,1 ± 8,2/88,3 ± 6,0, daytime BP 147,8 ± 8,8/90,2 ± 4,2 mmHg, night-time BP 131,7 ± 5,5/81,6 ± 4,8. After 12 weeks clinic BP was 131,5 ± 4,2/82,4 ± 5,4 mmHg, target BP 135/85 mmHg) was found in 7 %. Treatment with perindopril A 10 mg/indapamide 2,5 mg was associated with significant decrease in 24-h, day- and night-time ambulatory BP, daytime systolic BP variability and morning surge, improvement of night-peaker diurnal BP pattern. No hypotensive episodes with daytime BP 5,1 mmol/l were observed. Conclusion. In uncontrolled arterial hypertension change from monotherapy with nearly to high doses of ACEi or ARA or from combination of ACEI or ARA with another antihypertensive agent to fixed dose combination of perindopril A 10 mg/indapamide 2,5 mg results in a well-tolerated significant reduction in clinic and ambulatory BP with low rate of masked uncontrolled hypertension.
No takes yet. Share an insight, caveat, or question.
Павлова et al. (2012) studied uncontrolled arterial hypertension (n=46). perindopril/indapamide fixed-dose combination vs. prior monotherapy or combination therapy was evaluated on clinic and ambulatory blood pressure. Switching to a fixed-dose combination of perindopril /indapamide reduced clinic BP from 162.6/98.0 mmHg to 131.5/82.4 mmHg in uncontrolled hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: